Back to Market返回行情
95
950220.KQ NeoImmuneTech, Inc.
KOEHealthcare₩2,505-11.48%LatestMarket Cap: ₩11.79B
As of 2026-05-18 07:45
Valuation
P/E (TTM)
-2.58
PEG
—
P/B
1.47
P/S
19.34
EV/EBITDA
0.49
DCF Value
—
FCF Yield
-198.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.9%
Operating Margin
-3829.9%
Net Margin
-5132.6%
ROE
-61.4%
ROA
-39.1%
ROIC
-35.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | ₩527.0M | 100.0% | ₩-6.22B | ₩-7.55B | ₩-234.00 | — |
| Q4 2025 | ₩39.1M | 99.2% | ₩-5.90B | ₩-10.77B | ₩-64.26 | — |
| Q3 2025 | ₩18.3M | 100.0% | ₩-4.42B | ₩-5.70B | ₩-268.00 | — |
| Q2 2025 | ₩25.1M | 100.0% | ₩-6.80B | ₩-7.27B | ₩-371.00 | — |
| Q1 2025 | ₩13.2M | 100.0% | ₩-8.08B | ₩-8.30B | ₩-421.00 | — |
| Q4 2024 | ₩-920.4M | 100.0% | ₩-5.12B | ₩32.27B | ₩1,641.74 | — |
| Q3 2024 | ₩1.09B | 100.0% | ₩-11.50B | ₩-10.63B | ₩-541.00 | — |
| Q2 2024 | ₩0.00 | — | ₩-9.68B | ₩-10.01B | ₩-100.48 | — |
| Q1 2024 | ₩0.00 | — | ₩-11.00B | ₩-11.65B | ₩-117.00 | — |
| Q4 2023 | ₩0.00 | — | ₩-13.20B | ₩-11.71B | ₩-118.41 | — |
| Q3 2023 | ₩0.00 | — | ₩-13.42B | ₩-13.12B | ₩-132.69 | — |
| Q2 2023 | ₩0.00 | — | ₩-16.64B | ₩-16.48B | ₩-166.79 | — |